Please ensure Javascript is enabled for purposes of website accessibility
Accessibility Menu
Myomo Stock Quote

Myomo (NYSEMKT: MYO)

$2.72
(-3.5%)
-$0.10
Price as of April 17, 2024, 4:00 p.m. ET

Myomo Return vs. S&P

1 Year 5 Year 5 Year Annualized Since IPO
MYO +288.63% -92.51% -40.43% -99%
S&P +21.68% +73.88% +11.70% +108%

Myomo Company Info

Myomo, Inc. is a medical robotics company that develops, designs, and produces myoelectric orthotics for people with neuromuscular disorders. It offers MyoPro, an upper-limb orthosis designed to support the arm and restore function to the weakened or paralyzed arms of certain patients suffering from CVA stroke, brachial plexus injury, traumatic brain or spinal cord injury, ALS or other neuromuscular disease or injury. The company was founded by Stephen Kelly, John McBean, Mira Sahney, and Kailas N. Narendran on September 1, 2004 and is headquartered in Boston, MA.

News & Analysis

Valuation

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.